rcprofit

Novavax: Swine Flu Vaccine Maker's Shares Surge

Nanoviricides (NNVC.OB) another small bio-tech just put out a press release in relation to Swine Flu:

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.



www.businesswire.com/p...